Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

ASOcura

Request full access

Antisense oligonucleotide drugs for rare neurodegenerative diseases

ChinaFounded 2017

About ASOcura

ASOcura is a biopharmaceutical company specializing in the development of antisense oligonucleotide (ASO) drugs. Founded in 2017 by Yimin Hua, the principal inventor of Nusinersen, the company is headquartered in Suzhou, China.

The company's core focus is on creating therapies for rare, neurodegenerative diseases by targeting RNA splicing and RNA editing. Its drug development pipeline targets conditions such as Duchenne muscular dystrophy (DMD), spinocerebellar ataxia type 3 (SCA3), and Huntington's disease, aiming to provide effective treatments for patients with these spinal degenerative diseases.

ASOcura has secured significant funding to advance its research and clinical trials. In July 2023, it closed a pre-series A+ funding round with Herui Venture Capital. This was followed by a Series A funding round in July 2024, raising CNY 100 million from investors including SDIC Venture Capital. The company plans to use this capital to accelerate product development and apply for clinical trial registrations.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2017
Headquarters
China
Open positions
None listed
Dealroom signal
14.7/100
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jul 2024 $14M $55M Herui Venture Capital · SDIC Venture Capital ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

ASOcura website traffic

Latest recorded traffic for ASOcura is 300 monthly website visits.

Latest monthly visits300
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

ASOcura in its local ecosystem

Live from Dealroom

The ASOcura office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • SDIC Venture Capital
  • Herui Venture Capital
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about ASOcura on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ASOcura’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.